Form 4: Dorman Products Executive Sells Shares

Dorman Products' President of Heavy Duty, John McKnight, sold 2,000 shares of common stock for approximately $128.798 per share.

Summary

• John McKnight, President, Heavy Duty at Dorman Products, Inc. (DORM), sold 2,000 shares of the company's common stock.
• The transaction occurred on December 12, 2025, at a weighted average price of $128.798 per share.
• The shares were sold in multiple transactions with prices ranging from $128.53 to $129.26.
• Following this sale, McKnight directly beneficially owns 9,112.1061 shares of Dorman Products common stock.
• The sale was executed pursuant to a Rule 10b5-1(c) contract, instruction, or written plan.

Sentiment

Score: 5

Explanation: A neutral score. While insider selling can be perceived negatively, the disclosure of a 10b5-1 plan indicates the sale was pre-scheduled and not necessarily a reaction to new negative company information, thus mitigating strong negative sentiment.

Negatives

• John McKnight, President, Heavy Duty, sold 2,000 shares of Dorman Products common stock, which represents a reduction in his direct beneficial ownership.

Future Outlook

NA

Industry Context

This filing is a routine disclosure of an insider stock transaction and does not provide specific industry context or trends. It reflects an individual executive's portfolio management rather than a company-wide strategic move.

Stakeholder Impact

• Shareholders may view the insider sale with slight caution, although the presence of a 10b5-1 plan suggests it is a routine, pre-planned transaction rather than a signal of lack of confidence in the company's future performance.

Key Dates

Recommendation

The filing reports a routine insider sale under a 10b5-1 plan, which is a pre-scheduled transaction and typically does not reflect new information about the company's prospects. While insider selling can sometimes be a negative signal, the pre-planned nature mitigates this concern. There is no new fundamental information in this filing to warrant a change in investment thesis, thus a 'hold' recommendation is appropriate.

Keywords

Dorman Products, DORM, Insider Trading, Form 4, Stock Sale, John McKnight, Executive Compensation, 10b5-1 Plan